Category: Medical News

Acupuncture reduced headache days by 0.72 days and intensity significantly compared to control treatments Benefits persisted during follow-up, with continued reductions in headache days, intensity, duration, and medication use Effectiveness was consistent across chronic migraine and chronic tension-type headache subtypes

18 Long COVID patients completed a 12-week trial comparing handheld vagal nerve stimulation to no treatment The device was safe and well tolerated with no reported adverse events Improvements in depression, fatigue, and autonomic symptoms were observed but not statistically significant

Targeted nursing intervention cut fall rates from 19.8% to 7.1% in older cancer patients on chemotherapy Patients receiving preventive care had fewer severe injuries and better treatment adherence Study enrolled 210 patients aged 65+ with non-Hodgkin\’s lymphoma across 12 weeks

Percutaneous electrolysis ranked highest for pain relief (SUCRA = 98.5%) Dry needling was most effective for restoring elbow function Both treatments outperformed standard conservative care in short-term outcomes

Telerehabilitation was most effective for pain reduction at 8 and 12 weeks In-person care ranked highest for reducing disability at 4 and 12 weeks Both approaches improved different aspects of recovery in chronic low back pain

Meta-analysis of 17 studies (716 participants) examined Mulligan SNAGs for chronic low back pain Significant improvements in pain intensity (SMD = -0.78) and functional disability (SMD = -0.60) Lumbar extension mobility also improved, but evidence certainty was moderate to low

Functional and mobility limitations commonly emerge during middle age, with prevalence estimates typically falling between 15% and 25% across many studies Musculoskeletal pain, arthritis, and multimorbidity show the strongest associations with these limitations Mobility limitations are generally reported more frequently than functional limitations when both are assessed

DIVA is typically identified when healthcare workers fail twice or more to insert an IV, veins cannot be seen or felt, or the patient has a documented history of difficult access Key risk factors include obesity, chronic diseases, prior chemotherapy, and veins that are invisible or non-palpable Effective management combines specialised training, ultrasound guidance, and escalation protocols to improve patient safety

Both 15 mg and 30 mg daily doses of upadacitinib significantly improved arthritis symptoms compared to control treatments The two doses showed similar effectiveness, but the 30 mg dose had more adverse events including infections and liver enzyme elevations The 15 mg dose may offer a better balance of benefits and risks for rheumatoid arthritis patients